Rating History for Talis Biomedical Corp. (tlis) by BofA Securities
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 1/7/2022 | Derik de Bruin | Downgrade | Underperform (Neutral) |
3.00 (N/A) |
3.53 (4.38) |
24.08% | Details |
 |
|||||||
|
|||||||
